Together, they demonstrate that a fraction of breast cancer cells with reduced ZNF143 expression may show improved survival through an autophagic process by controlling the p53-Beclin1 axis, validating the requirement of limiting autophagy for the most effective therapy [13,59,60,61,62]. Here, ZNF143 is linked to breast carcinoma.